Obesity

Comparative Weight-Loss Outcomes Following Initiation of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors: A Real-World Active Comparator Study

Endocr PractPublished Retrospective cohort study

Authors' conclusion

GLP-1RA initiators achieved greater weight loss than SGLT2i initiators, concentrated in women and patients without type 2 diabetes

Study context

Population
Adults aged 18 to 80 with BMI ≥27 kg/m² and available weight measurements, NIH All of Us Research Program (2018–2023), diverse US cohort
Participants
2,932 vs 941
Exposure
GLP-1RA vs SGLT2 inhibitor (SGLT2i) initiation
  • GLP-1RAn = 2,932
  • SGLT2in = 941reference
Outcome
Percent body weight change
Follow-up
12 months
Methodological detailsactive comparator new-user design, inverse probability of treatment weighting, 17-covariate propensity score model
  • Active comparator new-user design
  • Inverse probability of treatment weighting
  • 17-covariate propensity score model

Main finding

As reported in the abstract

Each group vs SGLT2iDifference, pp (95% CI)P value
GLP-1RA
−1.20(−1.91 to −0.48)
P = 0.001
Each group vs SGLT2iEstimate (95% CI)
GLP-1RA
OR 1.75(1.40–2.19)
GLP-1RA
RR 1.61(1.19–2.03)
GLP-1RA initiators lost more weight than SGLT2i initiators; NNT
14

Observational data: associations, not effects.

Secondary outcomes

OutcomeEstimateP value
Percent body weight change, obesity-only subgroup · 12 monthsdifference −1.96 ppP < 0.001
Percent body weight change, T2D subgroup · 12 monthsdifference +0.08 ppinteraction P =.006
Percent body weight change by sex · 12 monthsGLP-1RA vs SGLT2i · women; P for sex effect modificationdifference −1.71 ppP = 0.017
Percent body weight change by sex · 12 monthsGLP-1RA vs SGLT2i · mendifference +0.12 pp
HbA1c changedifference −0.261 %P = 0.032

Blood pressure change

Blood pressure did not differ significantly

Original publication

Comparative Weight-Loss Outcomes Following Initiation of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors: A Real-World Active Comparator Study. Endocr Pract. Published 29 September 2026. doi:10.1016/j.eprac.2026.09.013

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.